Coppel, Scott
Mathur, Karan
Ekser, Burcin
Patidar, Kavish R.
Orman, Eric
Desai, Archita P.
Vilar-Gomez, Eduardo
Kubal, Chandrashekhar
Chalasani, Naga
Nephew, Lauren
Ghabril, Marwan http://orcid.org/0000-0002-4784-3246
Article History
Received: 2 August 2020
Accepted: 11 September 2020
First Online: 16 September 2020
Ethics approval and consent to participate
: This study was approved by the Indiana University institutional review board, and as a minimal risk study, consent to participate and publish was waived.
: The authors consent to the publication policy of the journal.
: Dr. Chalasani holds consulting agreements from several pharmaceutical companies for activities related to NAFLD, DILI and liver disease in general. His institution receives research grants on his behalf from Intercept, Lilly, Cumberland, Galectin, and Exact Sciences. But none represent a conflict of interest for this paper. Scott Coppel, Karanm Mathur, Lauren Nephew, Kavish Patidar, Eric Orman, Archita Desai, Eduardo Vilar-Gomez, Burcin Ekser, Chandrashekhar Kubal, and Marwan Ghabril report no potential conflicts of interest.